Psoriasis Research Review, Issue 74

In this issue:

Risankizumab vs secukinumab for moderate-to-severe plaque psoriasis
Risk of hospitalisation and death due to infection in psoriasis
Real-world use of apremilast in plaque psoriasis
Clobetasol vs calcipotriol/betamethasone dipropionate foam for plaque psoriasis
Methotrexate use and risk of cutaneous squamous cell carcinoma
Predicting risk of disease flares in biologic-naive patients
Ixekizumab for moderate-to-severe psoriasis
Psoriasis in challenging-to-treat body areas
Treatment of generalised pustular psoriasis
Psoriasis affects self-perception of stress
Long-term systemic treatment and hepatitis B virus infection
Effect of sex in systemic psoriasis therapy

Please login below to download this issue (PDF)

Subscribe